Pfizer and BioNTech request EUA for COVID-19 vaccine in young children


Picture by Marko Geber/Getty Photos

Pfizer and BioNTech have formally requested that their COVID-19 vaccine be cleared for use among the young small children.

In a tweet Thursday, Pfizer said the corporations submitted their request for an emergency use authorization (EUA) of their vaccine to the U.S. Foodstuff and Drug Administration. They are seeking clearance for it to be employed among the small children aged 5 to 11 decades previous.

The request for EUA will be evaluated through an future Vaccines and Similar Organic Products Advisory Committee (VRBPAC) assembly on October 26.

“We know from our broad practical experience with other pediatric vaccines that small children are not compact grown ups, and we will carry out a thorough analysis of clinical demo information submitted in assist of the protection and effectiveness of the vaccine employed in a more youthful pediatric populace, which may have to have a different dosage or formulation from that employed in an more mature pediatric populace or grown ups,” Acting Food and drug administration Commissioner Dr. Janet Woodcock said in a statement.

WHY THIS Issues

The EUA submission comes as no shock considering that the corporations said they would request regulatory approval “as shortly as probable” very last month when they launched vaccine information among the small children aged 5 to 11.

The information showed that a lesser dose of Pfizer and BioNTech’s vaccine elicited a identical antibody response and experienced similar facet consequences as viewed in persons 16 to twenty five decades of age.

As noted in Pfizer’s tweet, COVID-19 scenarios among the young small children are on the increase. For the duration of the 7 days of September thirty, 173,469 kid COVID-19 scenarios were being reported, symbolizing 26.7% of all scenarios recorded that 7 days, in accordance to the American Academy of Pediatrics.

In the two-7 days time period prior to September thirty, there was a 7% enhance in the cumulative quantity of kid COVID-19 scenarios considering that the starting of the pandemic, the AAP found.

“With new scenarios in small children in the U.S. continuing to be at a superior stage, this submission is an significant stage in our ongoing energy towards #COVID19,” Pfizer said in its tweet. “We’re fully commited to performing with the Food and drug administration with the supreme objective of aiding protect small children towards this critical community wellness risk.”

THE More substantial Craze

In August, Pfizer and BioNTech’s COVID-19 vaccine turned the initially to receive comprehensive approval from the Food and drug administration. The vaccine is now promoted as Comirnaty and is authorised for the avoidance of COVID-19 for people 16 decades previous and more mature.

The corporations have also gotten a EUA for a booster shot of Comirnaty among the particular populations, these kinds of as people sixty five decades of age and more mature, men and women 18 by 64  at superior possibility of extreme COVID-19 and people aged 18 by 64 whose occupational publicity places them at superior possibility of critical problems of COVID-19.

Moderna and Johnson & Johnson have also submitted requests to the Food and drug administration for booster shot EUAs. The VRBPAC has scheduled meetings for October 14 and fifteen to talk about probable booster shot approvals.

Twitter: @HackettMallory
Electronic mail the writer: [email protected]